Memorial Sloan Kettering Cancer Center Showcases Pioneering Cancer Research for World Cancer Research Day

From uncovering why young adults face rising cancer rates to pioneering vaccines and new therapies, MSK’s latest research is shaping the future of cancer care in the Middle East and worldwide.

DOHA, DUBAI, RIYADH. September 24, 2025. On World Cancer Research Day, Memorial Sloan Kettering Cancer Center (MSK) highlights pioneering research that is improving treatment options, expanding access to precision care, and offering hope to patients across the Middle East.

Key breakthroughs include:

“World Cancer Research Day reminds us that every discovery, from lab insights to new treatment strategies, has the potential to save lives,” says Dr. Ghassan Abou-Alfa, Gastrointestinal Medical Oncologist at MSK. “Our goal is to ensure these advances reach patients worldwide, including the Middle East, Africa, Eurasia, Asia, and the Americas, and directly improve outcomes. We aim to lead the way in innovations that treat, and ultimately prevent, cancer in the region.”

With more than 100 research laboratories, MSK maintains one of the world’s most dynamic programs of cancer research. The Sloan Kettering Institute (SKI), MSK’s basic research arm, is dedicated to understanding the biology of cancer and collaborates closely with MSK physician-scientists to accelerate discoveries from lab to patient. MSK also runs one of the world’s largest clinical trial programs.  

MSK continues to expand access to world-class care for patients from across the globe, including the Middle East, through innovative clinical trials, innovative vaccines, and transformative therapies, reflecting its mission to lead in cancer research, education, and clinical excellence.

### 

About Memorial Sloan Kettering Cancer Center (MSK)

The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 35 years. http://www.mskcc.org.